Last Updated: May 3, 2026

Details for New Drug Application (NDA): 021504

✉ Email this page to a colleague

NDA 021504 describes LIDOSITE TOPICAL SYSTEM KIT, which is a drug marketed by Vyteris and is included in one NDA. Additional details are available on the LIDOSITE TOPICAL SYSTEM KIT profile page.

The generic ingredient in LIDOSITE TOPICAL SYSTEM KIT is epinephrine; lidocaine hydrochloride. There are twenty-one drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the epinephrine; lidocaine hydrochloride profile page.

Summary for 021504

Tradename:	LIDOSITE TOPICAL SYSTEM KIT
Applicant:	Vyteris
Ingredient:	epinephrine; lidocaine hydrochloride
Patents:	0

Profile for product number 001

Active Rx/OTC/Discontinued:	DISCN	Dosage:	PATCH;IONTOPHORESIS, TOPICAL			Strength	1.05MG/PATCH;100MG/PATCH
Approval Date:	May 6, 2004	TE:		RLD:	No

Expired US Patents for NDA 021504

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Vyteris	LIDOSITE TOPICAL SYSTEM KIT	epinephrine; lidocaine hydrochloride	PATCH;IONTOPHORESIS, TOPICAL	021504-001	May 6, 2004	6,629,968	⤷ Start Trial
Vyteris	LIDOSITE TOPICAL SYSTEM KIT	epinephrine; lidocaine hydrochloride	PATCH;IONTOPHORESIS, TOPICAL	021504-001	May 6, 2004	6,377,847	⤷ Start Trial
Vyteris	LIDOSITE TOPICAL SYSTEM KIT	epinephrine; lidocaine hydrochloride	PATCH;IONTOPHORESIS, TOPICAL	021504-001	May 6, 2004	5,246,418	⤷ Start Trial
Vyteris	LIDOSITE TOPICAL SYSTEM KIT	epinephrine; lidocaine hydrochloride	PATCH;IONTOPHORESIS, TOPICAL	021504-001	May 6, 2004	6,385,488	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.